What does the NextGen CRC Panel at Metropolis Healthcare include?
It evaluates key colorectal cancer–associated genes for mutations that impact diagnosis, prognosis, and therapy options.
How does Metropolis Healthcare perform the CRC gene panel?
Metropolis Healthcare uses high-depth NGS and validated bioinformatics analysis to identify clinically relevant mutations.
Who should consider taking this test at Metropolis Healthcare?
Patients with confirmed or suspected colorectal cancer needing molecular insights for targeted or precision therapy should consider this panel.
Is fasting required for the NextGen CRC Panel at Metropolis Healthcare?
No fasting is needed; the test uses tumor tissue or blood samples as advised by the clinician.
How long do results take at Metropolis Healthcare?
Results typically take 2–3 weeks due to detailed sequencing and variant interpretation.
Can this test at Metropolis Healthcare help guide targeted therapy?
Yes, it identifies actionable mutations that inform targeted treatment strategies.
How accurate is the CRC NGS panel at Metropolis Healthcare?
Metropolis Healthcare ensures high analytical accuracy through deep sequencing coverage and strict quality control protocols.
Does this panel support long-term colorectal cancer management at Metropolis Healthcare?
Yes, the molecular insights assist clinicians in planning personalized treatment and monitoring strategies.